PTC Therapeutics, Inc. (PTCT)
77.29
+1.89
(+2.51%)
USD |
NASDAQ |
Jan 14, 16:00
77.28
-0.01
(-0.01%)
After-Hours: 20:00
PTC Therapeutics Research and Development Expense (TTM): 446.89M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Spyre Therapeutics, Inc. | 177.50M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |
| Theriva Biologics, Inc. | 10.36M |
| Oragenics, Inc. | 3.387M |